Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports consolidated transactions of securities and derivatives involving the Board of Directors, Management, and the Fiscal Council. The reporting period covers March 1, 2025, to March 31, 2025, in compliance with Article 11 of CVM Instruction #358/2002. The report was signed on April 9, 2024.
Key Financial Metrics and Transaction Data
The filing does not contain company-wide financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively details insider trading activity.
Board of Directors Transactions
- Initial Balance: 11,822,786 Common Shares; 1,244,220 ADRs.
- Acquisitions: 297,798 Common Shares (Delivery of restricted shares) at R$12.22.
- Dispositions: 7,000 Common Shares sold; 776,180 ADRs sold (276,180 via Merrill Lynch, 500,000 via JP Morgan).
- Final Balance: 12,113,584 Common Shares; 468,040 ADRs.
Management Transactions
- Initial Balance: 4,143,331 Common Shares; 19,790 ADRs.
- Acquisitions: 803,647 Common Shares (Restricted shares); 536,965 Common Shares (Stock Option Exercise).
- Dispositions: 393,046 Common Shares sold across multiple transactions.
- Final Balance: 5,090,897 Common Shares; 19,790 ADRs.
Fiscal Council Transactions
- Initial Balance: 0 Common Shares.
- Acquisitions: 500 Common Shares purchased via XP Corretora at R$13.62.
- Final Balance: 500 Common Shares.
Material Changes Versus Prior Period
The filing text does not provide comparative data for the prior period (e.g., February 2025) to calculate material changes in trading volume or position size. The document only presents the absolute balances and transactions for March 2025.
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies. It is a statutory disclosure of insider securities transactions only.
Important Facts for Investor Verification
- Net Insider Activity: Both the Board of Directors and Management groups increased their net holdings of Common Shares during March 2025, primarily driven by the delivery of restricted shares and stock option exercises.
- ADR Reduction: The Board of Directors significantly reduced its ADR holdings, selling 776,180 ADRs while increasing Common Share holdings.
- Transaction Prices: Insider transactions occurred at prices ranging from R$12.22 (restricted shares) to R$13.62 (market purchases), indicating the trading range for the month.
- Reporting Date Discrepancy: The report covers March 2025 but was signed on April 9, 2024. Investors should verify if this date reflects a filing error or a specific regulatory reporting lag.